Goldman Sachs Appoints Samuel Thong as Healthcare Group Chairman

Sam Thong Joins Goldman Sachs from Morgan Stanley

Thong to Lead Healthcare Investment Banking in Asia Ex-Japan

New York, May 13, 2023 - Goldman Sachs Group Inc (NYSE: GS) today announced the appointment of Samuel Thong as chairman of its healthcare group in Asia ex-Japan. Thong will be based in Hong Kong and report to Sam Levisohn, global co-head of Healthcare Investment Banking.

Thong joins Goldman Sachs from Morgan Stanley, where he served as a managing director and head of Healthcare Investment Banking in Asia ex-Japan. He has more than 20 years of experience in investment banking, with a focus on healthcare. Thong has advised on some of the region's largest and most complex healthcare transactions, including mergers and acquisitions, capital raisings, and strategic advisory.

Sam Levisohn, global co-head of Healthcare Investment Banking, said, "We are delighted to welcome Sam to Goldman Sachs. He is a highly respected and experienced investment banker with a deep understanding of the healthcare sector in Asia. Sam's appointment underscores our commitment to providing our clients with the best possible advice and execution in this important industry."

Thong said, "I am excited to join Goldman Sachs and contribute to the firm's continued success in Healthcare Investment Banking in Asia ex-Japan. Goldman Sachs has a long history of advising on the most transformative transactions in the healthcare sector, and I look forward to working with the team to build on this legacy."

The addition of Thong to Goldman Sachs' healthcare team further strengthens the firm's position as a leading provider of investment banking services to the healthcare industry. Goldman Sachs has a global healthcare team of over 100 professionals who provide a full range of services to clients, including mergers and acquisitions, capital raisings, and strategic advisory.